Peel Therapeutics
PrivateLast Round
Grant
Feb 23, 2023
Total Funding Raised
$39M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Peel Therapeutics operates in Healthcare & Life Sciences and is based in New York. Its latest recorded funding round was a Grant round in February 2023.
Peel Therapeutics is a biotechnology company that develops anti-cancer protein nanoparticles aimed at treating cancer by regulating cellular responses to environmental stresses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Peel Therapeutics Comparables
Compare Peel Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gibson Oncology, LLC | 80% | |
| Eris Biotech | 71% | |
| Sirenas Marine Discovery | 66% |
For institutional investors. Book with your work email.
Peel Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 23, 2023 | ||||
| Seed | Feb 23, 2023 | ||||
| Seed | Aug 10, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Peel Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 35% MoM.
For institutional investors. Book with your work email.
Peel Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Peel Therapeutics's valuation, stock price, and market status.
Is Peel Therapeutics a public or private company?
Peel Therapeutics is a private company.
What is the current stock price of Peel Therapeutics?
Peel Therapeutics is a private company, so its shares have no public market price. Caplight tracks Peel Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Peel Therapeutics worth (valuation)?
Valuation information for Peel Therapeutics is not publicly available.
Can I buy Peel Therapeutics stock?
Peel Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Peel Therapeutics's last funding round?
Peel Therapeutics's most recent funding round was Grant on February 23, 2023.
Who are the main investors in Peel Therapeutics?
Key investors in Peel Therapeutics include NIH RADx.
Will Peel Therapeutics IPO soon?
No public IPO plans have been announced for Peel Therapeutics.
How can I track Peel Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Peel Therapeutics's shares on secondary markets.